SCHEMBL29414698

SCHEMBL29414698

Cc1c(C(N)=O)c2ccccc2n1C

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.66
SRC P12931 5/20 0.66
KMT2A Q03164 5/20 0.56
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 2/20 0.53
GLA P06280 1/20 0.53
GAA P10253 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
HTT P42858 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MEN1 O00255 3/20 0.51
MAPT P10636 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 1/20 0.48
THRB P10828 1/20 0.48
TP53 P04637 1/20 0.47
GPR3 P46089 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671401 1.00 EGFR (0.66) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL30002195 0.88 KDM4E (0.61) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL984736 0.84 EGFR (0.65) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL30443220 0.84 EGFR (0.65) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL7278316 0.84 EGFR (0.65) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL9959370 0.82 KMT2A (0.56) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL28295413 0.81 GAA (0.55) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL8999049 0.81 EGFR (0.69) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL8702816 0.81 KMT2A (0.62) EGFRSRCKMT2AALDH1A1KDM4E
SCHEMBL28068134 0.81 EGFR (0.64) EGFRSRCKMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130095-A9 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-08-02 WO disclosed
EP-3965884-A1 MODULATORS OF THR-BETA AND METHODS OF USE THEREOF Aligos Therapeutics, Inc. (US) 2022-03-16 EP disclosed